Title : EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.

Pub. Date : 2021 Jun 15

PMID : 33903122






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EPHB2 activates beta-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma. Sorafenib EPH receptor B2 Homo sapiens
2 RNA-sequencing analysis of sorafenib-resistant PDXs and their corresponding mock controls identified EPHB2 as the most significantly upregulated kinase. Sorafenib EPH receptor B2 Homo sapiens